Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.380

-1.4%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who started this subject	10/26/2003 7:26:31 PM
From: richardred	of 7260

Current earnings look disappointing. Down the road looks bright due to developing generic versions of off patent medications for mass markets. As I understand the PR. Also a new step of developing off patent generic versions prescription drugs for a non OTC market. This looks to be just what the doctor ordered for PRGO-IMO. Higher margins with a very efficent manufacturing, to go along with a good customer mass market base. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next